<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00949403</url>
  </required_header>
  <id_info>
    <org_study_id>09-0621</org_study_id>
    <nct_id>NCT00949403</nct_id>
  </id_info>
  <brief_title>Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease</brief_title>
  <acronym>Liver</acronym>
  <official_title>An Interdisciplinary Approach to the Study of Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Barnes-Jewish Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how the liver receives and uses fats for energy.&#xD;
      This will help the investigators further understand the physical and chemical processes&#xD;
      responsible for Non-Alcoholic Fatty Liver Disease (NAFLD) in overweight females with or&#xD;
      without NAFLD who are scheduled to undergo gastric bypass surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study involves a multidisciplinary approach that will address the metabolic mechanisms&#xD;
      responsible for Non-alcoholic Fatty Liver Disease (NAFLD) in humans. Nonalcoholic fatty liver&#xD;
      disease (NAFLD) has become an important public health problem in many industrialized&#xD;
      countries because of its high prevalence, potential progression to severe liver disease, and&#xD;
      association with cardiometabolic abnormalities, including diabetes, the metabolic syndrome,&#xD;
      dilated cardiomyopathy, and coronary heart disease. Although obesity is an important risk&#xD;
      factor for NAFLD many obese persons have minimal or no steatosis. The mechanism responsible&#xD;
      for the pathogenesis of steatosis is not known, but must involve one or more of the&#xD;
      following:&#xD;
&#xD;
        1. Increased hepatic fatty acid (FA) delivery&#xD;
&#xD;
        2. Decreased hepatic FA oxidation&#xD;
&#xD;
        3. Increased de novo lipogenesis (DNL)&#xD;
&#xD;
        4. Inadequate hepatic triglyceride secretion&#xD;
&#xD;
      We hypothesize that alterations in all of these metabolic processes are involved in the&#xD;
      pathogenesis of NAFLD. However, a comprehensive evaluation of these factors in individual&#xD;
      cohorts of subjects has never been performed, and the ability to measure hepatic FA oxidation&#xD;
      in vivo in human subjects has not been available.&#xD;
&#xD;
      The following Specific Aims will be evaluated in obese women with and without NAFLD, who are&#xD;
      scheduled for bariatric surgery:&#xD;
&#xD;
        1. Determine hepatic FA uptake and oxidation by using novel PET techniques in combination&#xD;
           with measurements of DNL using stable isotope tracers and by assessing liver tissue FA&#xD;
           oxidative capacity by evaluating gene expression of FA oxidative enzymes and&#xD;
           mitochondrial content.&#xD;
&#xD;
        2. Determine hepatic fatty acid delivery by using stable isotope tracers to assess the rate&#xD;
           of free FA (FFA) release into plasma and cellular biology methods to determine the&#xD;
           expression and protein content of the major tissue FA transporter (CD36).&#xD;
&#xD;
        3. Determine hepatic very-low-density lipoprotein TG (VLDL-TG) secretion rate by using&#xD;
           stable isotope tracers.&#xD;
&#xD;
        4. Determine liver histology and factors involved in inflammation and fibrosis by using&#xD;
           routine staining and immunohistochemistry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">January 19, 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic Fatty Acid Oxidation</measure>
    <time_frame>3 hours</time_frame>
    <description>Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>Obese Females (pre-bariatric surgery)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twenty obese females (18-45 years of age, BMI &gt; or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years. They will be imaged with PET/CT and radiopharmaceuticals C-11 Acetate and C-11 Palmitate will be injected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Radio pharmaceuticals C-11 Acetate, and C-11 Palmitate</intervention_name>
    <description>injection of C-11 Palmitate and C-11 Acetate during PET/CT to determine Liver metabolism</description>
    <arm_group_label>Obese Females (pre-bariatric surgery)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obese females with a BMI of greater then or equal to 45.&#xD;
&#xD;
          -  Age range between 18-45 years.&#xD;
&#xD;
          -  Patients undergoing bariatric surgery at Barnes-Jewish Hospital-St.Louis,MO.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any prior history or evidence of liver disease other than Non-Alcoholic Fatty liver&#xD;
             Disease, severe hypertriglyceridemia and diabetes mellitis.&#xD;
&#xD;
          -  Consumed greater then or equal to 20 grams of alcohol per day.&#xD;
&#xD;
          -  Taking medications that are known to cause hepatic steatosis &amp; liver damage.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert J Gropler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>July 28, 2009</study_first_submitted>
  <study_first_submitted_qc>July 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2009</study_first_posted>
  <results_first_submitted>February 7, 2018</results_first_submitted>
  <results_first_submitted_qc>June 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 22, 2020</results_first_posted>
  <last_update_submitted>June 1, 2020</last_update_submitted>
  <last_update_submitted_qc>June 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-Alcoholic Fatty Liver disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiopharmaceuticals</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Obese Females (Pre-bariatric Surgery)</title>
          <description>Twenty obese females (18-45 years of age, BMI &gt; or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The PI has left the institution, all efforts to locate the data have been exhausted and therefore no results are available to be reported</population>
      <group_list>
        <group group_id="B1">
          <title>Obese Females (Pre-bariatric Surgery)</title>
          <description>Twenty obese females (18-45 years of age, BMI &gt; or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obese Females</title>
        </measure>
        <measure>
          <title>fatty acid in non-alcoholic Fatty Liver Disease</title>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hepatic Fatty Acid Oxidation</title>
        <description>Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.</description>
        <time_frame>3 hours</time_frame>
        <population>The PI has left the institution, all efforts to locate the data have been exhausted and therefore no results are available to be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Obese Females (Pre-bariatric Surgery)</title>
            <description>Twenty obese females (18-45 years of age, BMI &gt; or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Hepatic Fatty Acid Oxidation</title>
          <description>Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.</description>
          <population>The PI has left the institution, all efforts to locate the data have been exhausted and therefore no results are available to be reported.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1-2 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Obese Females (Pre-bariatric Surgery)</title>
          <description>Twenty obese females (18-45 years of age, BMI &gt; or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>there were no limitations or caveats</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory</name_or_title>
      <organization>Washington University School of Medicine</organization>
      <phone>314-747-3877</phone>
      <email>groplerr@mir.wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

